CStone Pharma shares jump after academic recognition of its lung-cancer treatment

CStone Pharma shares jump after academic recognition of its lung-cancer treatment

Source: 
Outsourcing Pharma
snippet: 

CStone Pharmaceuticals' shares have risen after academic journal Nature Cancer published the clinical study results of its lung-cancer treatment sugemalimab.